[Clinical evaluation of Trivé 1000 in surgery]

Trials with Trive 1000 allow to confirm its perfect tolerance and its real interest in N sparing effect provided a minimum of 1500 ml, or even better 2000 ml are perfused with an adequate caloric carboyhdrate complement. However, in severe cases such as septicemia, one may expect a positive N balance only with much more important supply of N and calories. Since there is almost no change in parameters refleting fat metabolism, one may suppose a normal utilisation of injected fat.